Late toxicities and recurrences in patients with clinical stage I non-seminomatous germ cell tumours after 1 cycle of adjuvant bleomycin, etoposide and cisplatin versus primary retroperitoneal lymph node dissection – A 13-year follow-up analysis of a phase III trial cohort

2021 ◽  
Vol 155 ◽  
pp. 64-72
Author(s):  
Andreas Hiester ◽  
Anna Fingerhut ◽  
Günter Niegisch ◽  
Roswitha Siener ◽  
Susanne Krege ◽  
...  
Keyword(s):  
Lymph Node ◽  
Clinical Stage ◽  
Phase Iii ◽  
Retroperitoneal Lymph Node Dissection ◽  
Germ Cell Tumours ◽  
Node Dissection ◽  
Retroperitoneal Lymph Node ◽  
Phase Iii Trial ◽  
Primary Retroperitoneal

Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node Dissection

Urology ◽  
2015 ◽  
Vol 86 (5) ◽  
pp. 981-984 ◽  
Author(s):  
Nick W. Liu ◽  
Clint Cary ◽  
Andrew C. Strine ◽  
Stephen D.W. Beck ◽  
Timothy A. Masterson ◽  
...  
Keyword(s):  
Lymph Node ◽  
Lymph Node Dissection ◽  
Clinical Stage ◽  
Stage I ◽  
Retroperitoneal Lymph Node Dissection ◽  
Node Dissection ◽  
Retroperitoneal Lymph Node ◽  
Risk Of Recurrence ◽  
Primary Retroperitoneal

Neoplasia del Testicolo: La Nostra Esperienza, Opinioni a Confronto

1994 ◽  
Vol 61 (1_suppl) ◽  
pp. 137-139
Author(s):  
M. Marzotto Caotorta ◽  
M. De Giovanni ◽  
M. Spinelli ◽  
E. Faccendini ◽  
F. Fanciullacci ◽  
...  
Keyword(s):  
Lymph Node ◽  
Germ Cell ◽  
Lymph Node Dissection ◽  
Retroperitoneal Lymph Node Dissection ◽  
Germ Cell Tumours ◽  
Node Dissection ◽  
Retroperitoneal Lymph Node ◽  
Pathological Staging ◽  
Diagnostic Investigations

We treated 79 patients with a neoplastic pathology of the testicle between 1972 and 1993. The average age of patients was 35 (range 17-75). Seminoma were treated with precautional and/or therapeutic cycles of TCT. In the 14 cases (38.8%) of non-seminomatous germ cell tumours (NSGCT) there was a difference between the clinical and the pathological staging after retroperitoneal lymph-node dissection (RPLND). Mortality due to progression of the disease was 3.8%. The 17 patients (47.2%) who underwent RPLND had an andrological follow-up (10 patients with normal ejaculation and 7 with no ejaculation). We confirm the under-staging of preliminary diagnostic investigations. Unlike some authors, we feel that conservative action (orchiectomy alone), is not sufficient even in first stage NSGCT.

Sign in / Sign up

Export Citation Format

Share Document